Scientists given means to exploit genome

March 9, 2001

A £4 million investment fund, backed by University College London, will help scientists exploit the human genome.

The Bloomsbury BioSeed Fund has been formed by a six-strong consortium of biomedical research centres including University College London, the Cancer Research Campaign, Imperial Cancer Research Fund, Institute of Cancer Research, London School of Pharmacy and the Royal Veterinary College.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments